Puma Biotechnology Inc (PBYI)
4.23
+0.06
(+1.44%)
USD |
NASDAQ |
May 22, 16:00
4.25
+0.02
(+0.47%)
After-Hours: 20:00
Puma Biotechnology Price to Book Value: 3.998 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 3.946 |
| May 20, 2024 | 4.135 |
| May 17, 2024 | 3.875 |
| May 16, 2024 | 4.173 |
| May 15, 2024 | 4.400 |
| May 14, 2024 | 4.674 |
| May 13, 2024 | 4.859 |
| May 10, 2024 | 4.551 |
| May 09, 2024 | 4.532 |
| May 08, 2024 | 4.570 |
| May 07, 2024 | 4.494 |
| May 06, 2024 | 4.371 |
| May 03, 2024 | 4.598 |
| May 02, 2024 | 4.693 |
| May 01, 2024 | 4.684 |
| April 30, 2024 | 4.797 |
| April 29, 2024 | 4.750 |
| April 26, 2024 | 4.750 |
| April 25, 2024 | 4.617 |
| April 24, 2024 | 4.570 |
| April 23, 2024 | 4.854 |
| April 22, 2024 | 4.892 |
| April 19, 2024 | 4.738 |
| April 18, 2024 | 4.719 |
| April 17, 2024 | 4.889 |
| Date | Value |
|---|---|
| April 16, 2024 | 4.823 |
| April 15, 2024 | 5.060 |
| April 12, 2024 | 4.984 |
| April 11, 2024 | 5.192 |
| April 10, 2024 | 5.225 |
| April 09, 2024 | 5.514 |
| April 08, 2024 | 5.324 |
| April 05, 2024 | 5.353 |
| April 04, 2024 | 5.211 |
| April 03, 2024 | 5.060 |
| April 02, 2024 | 4.993 |
| April 01, 2024 | 4.993 |
| March 31, 2024 | |
| March 28, 2024 | 4.781 |
| March 27, 2024 | 5.033 |
| March 26, 2024 | 5.052 |
| March 25, 2024 | 5.042 |
| March 22, 2024 | 4.808 |
| March 21, 2024 | 4.826 |
| March 20, 2024 | 4.235 |
| March 19, 2024 | 3.879 |
| March 18, 2024 | 4.204 |
| March 15, 2024 | 4.510 |
| March 14, 2024 | 4.709 |
| March 13, 2024 | 4.808 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.737
Minimum
Oct 25 2023
55.58
Maximum
May 13 2020
13.82
Average
10.28
Median
Price to Book Value Benchmarks
| ADMA Biologics Inc | 14.54 |
| Pfizer Inc | 1.818 |
| United Therapeutics Corp | 2.299 |
| Vanda Pharmaceuticals Inc | 0.5488 |
| Sarepta Therapeutics Inc | 12.60 |
Price to Book Value Related Metrics
| PE Ratio | 13.20 |
| PS Ratio | 0.8912 |
| PEG Ratio | 0.0692 |
| Price to Free Cash Flow | 5.672 |
| Price | 4.23 |
| Earnings Yield | 7.57% |
| Market Cap | 204.05M |
| PEGY Ratio | 0.0692 |
| Operating PE Ratio | 7.593 |
| Normalized PE Ratio | 12.70 |